Barry Kenny

1.1k total citations
19 papers, 951 citations indexed

About

Barry Kenny is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Urology. According to data from OpenAlex, Barry Kenny has authored 19 papers receiving a total of 951 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 11 papers in Cellular and Molecular Neuroscience and 4 papers in Urology. Recurrent topics in Barry Kenny's work include Neuroscience and Neuropharmacology Research (8 papers), Receptor Mechanisms and Signaling (7 papers) and Ion channel regulation and function (5 papers). Barry Kenny is often cited by papers focused on Neuroscience and Neuropharmacology Research (8 papers), Receptor Mechanisms and Signaling (7 papers) and Ion channel regulation and function (5 papers). Barry Kenny collaborates with scholars based in United Kingdom, France and Czechia. Barry Kenny's co-authors include A.M. Naylor, Derek Chalmers, MartinC. Michel, Debra A. Schwinn, Stephen A. Ballard, David Fox, Julian Blagg, Michael Spedding, Michael G. Wyllie and Pamela Greengrass and has published in prestigious journals such as Journal of Medicinal Chemistry, Trends in Pharmacological Sciences and British Journal of Pharmacology.

In The Last Decade

Barry Kenny

19 papers receiving 882 citations

Peers

Countries citing papers authored by Barry Kenny

Since Specialization

Citations

This map shows the geographic impact of Barry Kenny's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barry Kenny with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barry Kenny more than expected).

Fields of papers citing papers by Barry Kenny

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barry Kenny. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barry Kenny. The network helps show where Barry Kenny may publish in the future.

Co-authorship network of co-authors of Barry Kenny

This figure shows the co-authorship network connecting the top 25 collaborators of Barry Kenny. A scholar is included among the top collaborators of Barry Kenny based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barry Kenny. Barry Kenny is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	From East to West: A Japanese Pharma perspective on establishing a global research capability 2009 ·Drug Discovery Today ·(unknown), Barry Kenny, (unknown)	1
2	The application of high-throughput screening to novel lead discovery 1998 ·Birkhäuser Basel eBooks ·Barry Kenny, Mark Bushfield, David Parry-Smith, (unknown), J. Mark Treherne	46
3	Progress in Drug Research 1998 ·Birkhäuser Basel eBooks ·(unknown), Eric J. Lien, Nicholas C. Turner, John C. Clapham, László Prókai, R. Wagey, Charles Krieger, (unknown), Kirk W. Johnson, Lee A. Phebus, Marlene L. Cohen, Barry Kenny, Mark Bushfield, David Parry-Smith, Simon W. Fogarty, J. Mark Treherne	11
4	Pharmacological Options in the Treatment of Benign Prostatic Hyperplasia 1997 ·Journal of Medicinal Chemistry ·Barry Kenny, Stephen A. Ballard, Julian Blagg, David Fox	145
5	Evaluation of the pharmacological selectivity profile of α₁ adrenoceptor antagonists at prostatic α₁ adrenoceptors: binding, functional and in vivo studies 1996 ·British Journal of Pharmacology ·Barry Kenny, (unknown), I.J.R. Williamson, John B. O’Connell, Derek Chalmers, A.M. Naylor	97
6	Neuroprotective properties of lifarizine compared with those of other agents in a mouse model of focal cerebral ischaemia 1995 ·British Journal of Pharmacology ·Christine M. Brown, (unknown), (unknown), Catherine B. Small, Barry Kenny, Michael Spedding, Leslie Patmore	20
7	Classification of ?1-adrenoceptor subtypes 1995 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·MartinC. Michel, Barry Kenny, Debra A. Schwinn	162
8	Characterization of an α_1D‐adrenoceptor mediating the contractile response of rat aorta to noradrenaline 1995 ·British Journal of Pharmacology ·Barry Kenny, Derek Chalmers, (unknown), A.M. Naylor	175
9	Section Review Central & Peripheral Nervous Systems: α₁-Adrenoceptor antagonists as treatments for benign prostatic hyperplasia 1995 ·Expert Opinion on Investigational Drugs ·Barry Kenny, Alan Collis, A.M. Naylor, Michael G. Wyllie	7
10	New drug binding sites in Ca2+ channels 1995 ·Trends in Pharmacological Sciences ·Michael Spedding, Barry Kenny, Pierre Chatelain	26
11	Pharmacological properties of the cloned α_1A/D‐adrenoceptor subtype are consistent with the α_1A‐adrenoceptor characterized in rat cerebral cortex and vas deferens 1994 ·British Journal of Pharmacology ·Barry Kenny, A.M. Naylor, Pamela Greengrass, Michael J. Russell, (unknown), (unknown), Michael G. Wyllie	41
12	Effect of alpha, adrenoceptorantagonists on prostatic pressure and blood pressure in the anesthetized dog 1994 ·Urology ·Barry Kenny, A.M. Naylor, (unknown), (unknown), Pamela Greengrass, Michael G. Wyllie	60
13	Modulation of α1-Adrenoceptors in Rat Left Ventricle by Ischaemia and Acyl Carnitines 1993 ·Journal of Cardiovascular Pharmacology ·(unknown), Christopher M. Brown, Barry Kenny, A.T. Kilpatrick, Arnold R. Martin, Michael Spedding	42
14	Changes in [³H]‐PK 11195 and [³H]‐8‐OH‐DPAT binding following forebrain ischaemia in the gerbil 1993 ·British Journal of Pharmacology ·Barry Kenny, Alison C. MacKinnon, Michael Spedding, Christine M. Brown	3
15	Identification of a novel calcium antagonist binding site in rat brain by SR 33557 1993 ·British Journal of Pharmacology ·Barry Kenny, Stuart T. Fraser, (unknown)	9
16	[³H]‐RS‐15385–197, a selective and high affinity radioligand for α₂‐adrenoceptors: implications for receptor classification 1992 ·British Journal of Pharmacology ·Alison C. MacKinnon, A.T. Kilpatrick, Barry Kenny, (unknown), Christine M. Brown	33
17	Voltage-dependent calcium channels: structures and drug-binding sites 1992 ·Biochemical Society Transactions ·Michael Spedding, Barry Kenny	6
18	Selective antagonism of calcium channel activators by fluspirilene 1990 ·British Journal of Pharmacology ·Barry Kenny, Stuart T. Fraser, A.T. Kilpatrick, Michael Spedding	8
19	Muscarinic activity of McN‐A‐343 and its value in muscarinic receptor classification 1987 ·British Journal of Pharmacology ·Richard M. Eglen, Barry Kenny, A.D. Michel, R.L. Whiting	59

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact